Announced Mon, 11 Aug · 15:19 IST

Akums Drugs and Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Akums Drugs and Pharmaceuticals has informed exchanges that it will attend the Emkay Confluence 2025 (Emkay Confluence – India Ascending: The Next Leap) on 14th August 2025. The meet will be held in person at Trident BKC, Mumbai. The company clarified that no unpublished price sensitive information (UPSI) will be shared at the meet. The disclosure is filed under Regulation 30 of SEBI LODR, and the schedule may change due to exigencies. The event details have also been updated on the company's website (www.akums.in).

Likely market impact

This is a routine regulatory disclosure about an investor conference attendance and has no direct material impact on the stock. Investors should note that the company will not share any new price-sensitive information at the meet, so no immediate price catalyst is expected from this event.